New UCF Nanotech Gives Boost to Detection of Cancer and Disease
The technique uses nickel-platinum nanoparticles to increase the sensitivity of an enzyme-linked immunosorbent assay, or ELISA, that is used to test for the presence of cancers, HIV and more
Early screening can mean the difference between life and death in a cancer and disease diagnosis. That’s why University of Central Florida researchers are working to develop a new screening technique that’s more than 300 times as effective at detecting a biomarker for diseases like cancer than current methods.
The technique, which was detailed recently in the Journal of the American Chemical Society, uses nanoparticles with nickel-rich cores and platinum-rich shells to increase the sensitivity of an enzyme-linked immunosorbent assay (ELISA).
ELISA is a test that measures samples for biochemicals, such as antibodies and proteins, which can indicate the presence of cancer, HIV, pregnancy and more. When a biochemical is detected, the test generates a color output that can be used to quantify its concentration. The stronger the color is, the stronger the concentration. The tests must be sensitive to prevent false negatives that could delay treatment or interventions.
In the study, the researchers found that when the nanoparticles were used in place of the conventional enzyme used in an ELISA — peroxidase — that the test was 300 times more sensitive at detecting carcinoembryonic antigen, a biomarker sometimes used to detect colorectal cancers.
And while a biomarker for colorectal cancer was used in the study, the technique could be used to detect biomarkers for other types of cancers and diseases, says Xiaohu Xia, an assistant professor in UCF’s Department of Chemistry and study co-author.
Colorectal cancer is the third leading cause of cancer-related deaths in the U.S., not counting some kinds of skin cancer, and early detection helps improve treatment outcomes, according to the U.S. Centers for Disease Control and Prevention.
The increase in sensitivity comes from nickel-platinum nanoparticle “mimics” that greatly increase the reaction efficiency of the test, which increases its color output, and thus its detection ability, Xia says.
Peroxidases found in the horseradish root have been widely used to generate color in diagnostic tests for decades. However, they have limited reaction efficiency and thus color output, which has inhibited the development of sensitive diagnostic tests, Xia says.
Nanoparticle “mimics” of peroxidase have been extensively developed over the past 10 years, but none have achieved the reaction efficiency of the nanoparticles developed by Xia and his team.
“This work sets the record for the catalytic efficiency of peroxidase mimic,” Xia says. “It breaks through the limitation of catalytic efficiency of peroxidase mimics, which is a long-standing challenge in the field.”
“Such a breakthrough enables highly sensitive detection of cancer biomarkers with the ultimate goal of saving lives through earlier detection of cancers,” he says.
Xia says next steps for the research are to continue to refine the technology and apply it to clinical samples of human patients to study its performance.
“We hope the technology can be eventually used in clinical diagnostic laboratories in the near future,” Xia says.
Original Article: New UCF Nanotech Gives Boost to Detection of Cancer and Disease
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Enzyme-linked immunosorbent assay
- How and when do de novo SARS-CoV-2 spike mutations emerge?
Mutations in SARS-CoV-2 have been associated with enhanced transmissibility, immune escape, resistance to therapeutics, and impaired diagnostic detection. Several SARS-CoV-2 variants of concern (VOCs) ...
- Global Enzyme Linked Immunosorbent Assay (Elisa) Market Size Is Expected To Grow At A Cagr Of Approx. 6% From 2022 To 2032
Evolve Business Intelligence published a new market research report on Global Enzyme Linked Immunosorbent Assay Market by Method (Direct ELISA, Indirect ELISA, Sandwich ELISA and Competitive ELISA ...
- The nose key to winning the war against COVID-19
In the present study, researchers compare both cellular and humoral responses against SARS-CoV-2 in the bronchoalveolar lavage (BAL) fluid and blood samples obtained from previously hospitalized ...
- Low-abundance biomarker detection platform for early disease diagnosis
Yu Lei, professor of chemical and biomolecular engineering, has invented a new platform that can perform high-sensitivity readings for a variety of disease biomarkers.
- Global Enzyme Linked Immunosorbent Assay (ELISA) Market to Surpass US$ 3,004.3 Million by 2030, Says Coherent Market Insights (CMI)
Seattle, July 22, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global Enzyme Linked Immunosorbent Assay (ELISA) market is estimated to be valued at US$ 2,016.1 million in 2022 ...
Go deeper with Google Headlines on:
Enzyme-linked immunosorbent assay
Go deeper with Bing News on:
Detection of cancer biomarkers
- Published UCLA and Spectrum Solutions Saliva Liquid Biopsy Research Highlights Signal Amplifying Ability and Clear Detection of Cancer Biomarkers
Spectrum Solutions, LLC today announced the publishing of findings from their research collaboration with the University of California at Los Angeles (UCLA) and Dr. David Wong, UCLA School of ...
- causaLens Partners With Mayo Clinic to Discover Biomarkers of Cancer Using Causal AI
Jul 26, 2022--causaLens, the London deep tech company delivering the future of AI, has utilized its Causal AI technology in an important step towards adop ...
- Novel sensor allows the detection of Alzheimer's 17 years in advance
A research team at the Ruhr-Universität Bochum has developed a new sensor that is able to identify signs of Alzheimer's disease in the blood up to 17 years before the first clinical symptoms appear.
- Nano Pom-Poms: A New Method to Detect Cancer Biomarkers
Study: Nano pom-poms prepared exosomes enable highly specific cancer biomarker detection. Image Credit: Meletios Verras/Shutterstock.com In an article published in the journal Communications Biology, ...
- Liquid Biopsy: A Pathway to Earlier and Less Invasive Cancer Detection
New methods, however, now allow scientists to use biomarkers in non-invasive liquid samples, like blood or urine, to detect cancer. The most studied biomarkers so far for liquid biopsy include ...